The Asia Pacific biosurgical agents market is primarily driven by growing surgical procedure volumes due to expanding aging population and the rising prevalence of diseases associated with aging, obesity, diabetes, and cardiovascular disease, in addition to rising awareness of the clinical benefits of these products on surgical outcomes, and the introduction of new products with enhanced features and expanded indications. However, growing concerns over product cost and competition from local competitors will limit ASP growth in this market, thus hindering revenue expansion to some extent.

This Medtech 360 Report provides high-level market metrics for surgical hemostats, internal tissue sealants, and adhesion barriers in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.

Table of contents

  • Asia Pacific (Supplemental)
    • Abstract
    • Key Report Updates
    • Biosurgical Agent Market
      • Market Definitions
        • Geographies Covered
        • Products Covered
      • Market Forecast Data
    • Surgical Hemostat Market
      • Market Definitions
      • Market Forecast Data
    • Internal Tissue Sealant Market
      • Market Definitions
      • Market Forecast Data
    • Adhesion Barrier Market
      • Market Definitions
      • Market Forecast Data
    • Appendix
      • Abbreviations

Author(s): Sumit Jain, MS Pharm

Sumit Jain is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at DRG (Part of Clarivate), focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor's degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master's degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.


Related Reports

Biosurgical Agents | Medtech 360 | Market Insights | Europe (Supplemental)

The biosurgical agent market in Europe is primarily driven by growing surgical procedure volumes, rising awareness of the benefits of these products in surgical outcomes,...

View Details

Biosurgical Agents | Medtech 360 | Market Insights | Asia Pacific

The Asia Pacific biosurgical agents market is primarily driven by growing surgical procedure volumes due to expanding aging population and the rising prevalence of diseases associated...

View Details

Biosurgical Agents | Medtech 360 | Market Insights | Europe

The biosurgical agent market in Europe is primarily driven by growing surgical procedure volumes, rising awareness of the benefits of these products in surgical outcomes, and the in...

View Details

Biosurgical Agents | Medtech 360 | Market Insights | Japan

The biosurgical agent market in Japan will grow moderately, driven by rising surgical procedure volumes, the introduction of new products, and expanding indications for the existing products.&nb...

View Details